General Guidelines
siRNA targeted sequence is usually 21 nt in length.
Avoid regions within 50-100 bp of the start codon and the termination codon
Avoid intron regions
Avoid stretches of 4 or more bases such as AAAA, CCCC
Avoid regions with GC content <30% or > 60%.
Avoid repeats and low complex sequence
Avoid single nucleotide polymorphism (SNP) sites
Perform BLAST homology search to avoid off-target effects on other genes or sequences
Always design negative controls by scrambling targeted siRNA sequence. The control RNA should have the same length and nucleotide composition as the siRNA but have at least 4-5 bases mismatched to the siRNA. Make sure the scrambling will not create new homology to other genes.
Tom Tuschl's rules
Select targeted region from a given cDNA sequence beginning 50-100 nt downstream of start condon
First search for 23-nt sequence motif AA(N<sub>19). If no suitable sequence is found, then,
Search for 23-nt sequence motif NA(N<sub>21) and convert the 3' end of the sense siRNA to TT
Or search for NAR(N<sub>17)YNN
Target sequence should have a GC content of around 50%
A = Adenine; T = Thymine; R = Adenine or Guanine (Purines); Y = Thymine or Cytosine (Pyrimidines); N = Any.
Rational siRNA design
By experimentally analyzing the silencing efficiency of 180 siRNAs targeting the mRNA of two genes and correlating it with various sequence features of individual siRNAs, Reynolds et al at Dharmacon, Inc identified eight characteristics associated with siRNA functionality. These characteristics are used by rational siRNA design algorithm to evaluate potential targeted sequences and assign scores to them. Sequences with higher scores will have higher chance of success in RNAi. The table below lists the 8 criteria and the methods of score assignment.
Criteria | Description | Score | |
Yes | No | ||
| 1 | Moderate to low (30%-52%) GC Content | 1 point | |
| 2 | At least 3 A/Us at positions 15-19 (sense) | 1 point /per A or U | |
| 3 | Lack of internal repeats (Tm*<20¡ãC) | 1 point | |
| 4 | A at position 19 (sense) | 1 point | |
| 5 | A at position 3 (sense) | 1 point | |
| 6 | U at position 10 (sense) | 1 point | |
| 7 | No G/C at position 19 (sense) | -1 point | |
| 8 | No G at position 13 (sense) | -1 point |
A sum score of 6 defines the cutoff for selecting siRNAs. All siRNAs scoring higher than 6 are acceptable candidates.
*Tm = 79.8 + 18.5*log<sub>10([Na+]) + (58.4 * GC%/100) + (11.8 * (GC%/100)2) - (820/Length)
For example, the Tm can be calculated as follows for the siRNA UUCUCCAGCUUCUAAAAUA
Tm = 79.8 + 18.5*log<sub>10(0.05) + (58.4 * 31.6/100) + (11.8 * (31.6/100)2) - (820/19)
Tm = 32.19
There are two siRNA design tools which implement this siRNA design algorithm: one is offered by Dharmacon, Inc; the other is a downloadable Excel template, written by Maurice Ho at http://boz094.ust.hk/RNAi/siRNA.
References
Elbashir SM et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-498.
Elbahir SM et al. (2001). Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20:6877-6888.
Elbashir SM et al. (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 26:199-213.
Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol. 2004 Mar;22(3):326-30.
http://www.basic.northwestern.edu/biotools/oligocalc.html
Maurice Ho, Rational siRNA Design
据27日《自然》杂志报道,英国伦敦大学学院(UCL)化学家通过模拟早期地球的条件,首次实现了RNA与氨基酸的化学连接。这一难题自20世纪70年代以来一直困扰着科学家,如今,这一突破性成果为解答生命起源......
美国芝加哥大学团队开发了一种更为灵敏的液体活检技术,该方法利用RNA而不是传统的DNA来检测癌症。这一创新方法在使用患者血液样本进行测试时,识别出早期结直肠癌的准确率达到95%,显著优于现有的非侵入性......
由新加坡科技研究局基因组研究所领导的科学家团队,发布了迄今全球最大、最全面的长读长RNA测序数据集之一——新加坡纳米孔表达数据集(SG-NEx)。这一成果有望解决疾病研究中长期存在的技术瓶颈,使研究人......
4月15日,中国工程院院士、中国科学院亚热带农业生态研究所首席研究员印遇龙领衔的单胃动物营养研究团队在科技合作和成果转化上取得新进展。其团队博士生王芳以“RNA技术研发与产业化应用”为主的项目,历经初......
近日,中山大学生命科学学院教授张锐团队首次提出名为MIRROR的全新内源性ADAR招募gRNA设计理念,显著提高了RNA编辑效率,这一突破为RNA编辑技术走向临床应用注入了强劲动力,同时也为相关疾病的......
中国科学院分子细胞科学卓越创新中心陈玲玲研究组揭示了双链RNA依赖的蛋白激酶R(PKR)在阿尔茨海默病(AD)发生与进展过程中异常激活的分子病理特征,开发了基于具有分子内短双链结构环形RNA(ds-c......
siRNA能抑制特定致癌基因表达,展现出较好的抗肿瘤潜力。然而其临床应用面临多重障碍,如负电荷亲水性阻碍细胞摄取,溶酶体逃逸能力不足导致降解风险,肿瘤靶向性差以及易被肾脏快速清除。尤其在治疗脑胶质瘤时......
在癌症治疗领域,化疗药物耐药性问题一直是阻碍治疗效果提升的关键瓶颈。癌细胞拥有多种复杂的机制,能够巧妙地逃避化疗药物的“攻击”,其中,高活性的抗氧化系统可以有效减轻药物诱导的活性氧(ROS)损伤,成为......
比利时布鲁塞尔自由大学主导的一项研究揭示,DNA和RNA的表观遗传学协同调控比过去想象的更加紧密。这项发表在最新一期《细胞》杂志上的研究,结合了DNA和RNA研究结果,指出这两种调控方式共同作用,形成......
近日,广州医科大学-中国科学院广州生物医药与健康研究院联合生命科学学院特聘教授、广州实验室研究员苗智超团队与合作者,对来自全球18个团队的预测进行了大规模评估,涉及23个RNA结构,包括RNA元件、适......